Advancing the science of palliative care research across the lifespan (ascent) consortium - ascent: overall project summary/abstract across the lifespan, people living with serious illness suffer…

Active Cooperative Agreement Awarded Last action

Award ID
U54AG093230
Recipient
Awarding agency
Obligated
$9,229,090

Award facts

Assistance listing
93.361 Nursing Research
Completion date 24% complete
Funding agency
National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services
Place of performance
Aurora, CO 80045, USA

Award details come from USAspending.gov.

Description

Advancing the science of palliative care research across the lifespan (ascent) consortium - ascent: overall project summary/abstract across the lifespan, people living with serious illness suffer physically, psychosocially and financially. The health system too often fails to deliver appropriate, effective care and persons with serious illness (pwsi) frequently experience mismatches between their goals for care and the treatments received. Palliative care (PC) meets the needs of pwsi and their caregivers by focusing on achieving the best possible quality of life while receiving life-prolonging and curative treatments as is congruent with patient goals of care. PC is appropriate from the point of diagnosis throughout the trajectory of a serious illness for persons of any age, with diagnoses including cancer, alzheimer's disease and alzheimer's disease related dementias (ad/adrd), advanced organ diseases (including heart, lung, liver, kidney), stroke, neuro-muscular degenerative diseases, genetic disorders and rare congenital and metabolic disorders, among others. While there have been significant gains in the past 2 decades, the evidence base to guide and improve PC - and thus to improve the quality of life for pwsi and their caregivers - remains inadequate. We thus urgently need to expand the PC evidence base and create a robust field capable of creating that evidence base. The advancing the science of palliative care research across the lifespan (ascent) consortium will be a national consortium of experts in PC that will advance innovative, high-quality research to improve care for people living with serious illness by providing resources and expertise in a coordinated manner. Specifically, the ascent consortium will: 1) develop the national scientific infrastructure and community needed to advance PC research. The ascent community will include scientists, healthcare systems, community-based organizations, clinicians, advocates, patients and caregivers to inform research priorities, study design, and dissemination strategies to maximize the relevance and impact of ascent. 2) create new PC research knowledge and research methodologies by conducting developmental projects, creating a PC research methodology and career development curriculum, and supporting the work of PC scientists via funding and provision of resources and expert consultation. 3) foster career development and impact of the PC field by supporting career development and pilot awards, providing access to methodologic consultations, and mentoring scientists. 4) disseminate PC research findings and facilitate subsequent adoption and implementation, employing a multi-pronged approach to dissemination. Through these 4 specific aims, the ascent consortium will transform the field of PC research, generating new knowledge and methods, developing and expanding the palliative care field, and facilitating implementation to enhance the experience of pwsi and their caregivers across the lifespan.

Transactions

Action Obligated Date
Amendment $100,000
Amendment $261,000
Amendment $0
Amendment -$261,000
Amendment $161,000
Amendment $0
Amendment $261,000
Amendment $0
Amendment $255,289
Amendment $255,289
Amendment $255,289
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $6,664,050
Amendment $100,000
Original award $200,000
Show all 25

Subawards

Subrecipient Amount Awarded
Rutgers The State University Of New Jersey Advancing the Science of Palliative Care Research Across the Lifespan (ASCENT) Consortium $299,148
Dana-Farber Cancer Institute, Inc. $161,652
Phoenix Children's Hospital, Inc. $162,000
Dana-Farber Cancer Institute, Inc. $161,626
The Ohio State University $161,800
The Ohio State University $160,120
Brigham & Womens Hospital Inc. $72,244
The General Hospital Corporation $132,734
Icahn School Of Medicine At Mount Sinai $354,473
Icahn School Of Medicine At Mount Sinai $223,404
The Trustees Of The University Of Pennsylvania $71,547
Dana-Farber Cancer Institute, Inc. $48,961
Duke University $567,792
The Leland Stanford Junior University $30,710
The University Of Texas Health Science Center At San Antonio $38,379
The Rand Corporation $37,126
Dana-Farber Cancer Institute, Inc. $80,695
Emory University $37,192
New York University $435,338
Yale Univ $42,164
Sloan-Kettering Institute For Cancer Research $70,001
The Johns Hopkins University $275,863
Trustees Of Boston College $38,972
The Regents Of The University Of California. San Francisco $245,867
University Of North Carolina At Chapel Hill $173,358
Trustees Of Indiana University $229,160
University Of Alabama At Birmingham $95,713
The Children's Hospital Of Philadelphia $108,866
Show all 28

Quick answers

Who received award U54AG093230?

U54AG093230 was awarded to The Regents Of The University Of Colorado by National Institute on Aging (National Institutes of Health) on August 6, 2025.

How much is award U54AG093230 worth?

$9,229,090 has been obligated on U54AG093230.

Which agency awarded U54AG093230?

National Institute on Aging (National Institutes of Health) awarded U54AG093230, with funding from National Institute of Child Health and Human Development (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award